Table 1 Characteristics of study population

Age ≥ 65

73 (76.8)

204 (80.6)

0.43

59 (73.8)

167 (77.3)

0.52

14 (93.3)

37 (100)

0.29

White

75 (79.0)

205 (83.3)

0.34

63 (78.8)

177 (84.7)

0.23

12 (80)

28 (75.7)

1.0

Male

89 (93.7)

238 (94.1)

0.89

76 (95.0)

201 (93.1)

0.79

13 (86.7)

37 (100)

0.08

PCP is a resident

10 (10.5)

30 (11.9)

0.73

8 (10.0)

26 (12.0)

0.63

2 (13.3)

4 (10.8)

1.0

PCP is in Women’s Health Clinic

5 (5.3)

8 (3.2)

0.36

4 (5.0)

8 (3.7)

0.74

1 (6.7)

0 (0

0.29

Had a GI procedure

n/a

n/a

n/a

5 (6.3)

17 (7.9)

0.64

n/a

n/a

n/a

Was seen in a GI clinic

n/a

n/a

n/a

19 (23.8)

76 (35.2)

0.061

n/a

n/a

n/a

Diagnosis of GI condition

n/a

n/a

n/a

29 (36.3)

106 (49.1)

0.049

n/a

n/a

n/a

Glucocorticoid use^b 

n/a

n/a

n/a

3 (3.8)

19 (8.8)

0.21

n/a

n/a

n/a

NSAID use^b

n/a

n/a

n/a

45 (56.3)

111 (51.4)

0.46

n/a

n/a

n/a

Clopidogrel use^b 

n/a

n/a

n/a

3 (3.8)

11 (5.1)

0.77

n/a

n/a

n/a

Insulin (rather than sulfonylurea) use

n/a

n/a

n/a

n/a

n/a

n/a

10 (66.7)

15 (40.5)

0.088

Diagnosis of renal Impairment (Creatinine > 2 mg/dL)

n/a

n/a

n/a

n/a

n/a

n/a

6 (40)

5 (13.5)

0.034

Diagnosis of cognitive impairment or dementia

n/a

n/a

n/a

n/a

n/a

n/a

1 (6.7)

5 (13.5)

0.66

Visit to an endocrine clinic

n/a

n/a

n/a

n/a

n/a

n/a

7 (46.7)

7 (18.9)

0.041

History of hypoglycemia

n/a

n/a

n/a

n/a

n/a

n/a

0

0

–